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Abstract 
Four quarantined vervet monkeys were treated with intramuscular BerenilR in patent CNS 
infection after experimental trypanosome inoculation with Typanosoma brucei rhodesiense or T. brucei 
brucei. All four animals relapsed in the post-therapeutic survival time of 37 to 209 days when they had 
fully developed me~ngoencepha~tis n histological sections with the presence of interstitial 
intracerebral trypanosomes, which were confirmed in two monkeys by electron microscopy. In both, 
sequential samples of the serum and cerebrospinal fluid were analysed for circulating immune 
complexes, immunoglobulins and albumin. From these results the intracerebral IgG synthesis and the 
impairment of the blood-brain-barrier were calculated, both being present in advanced infection. 
Circulating immune complexes were present in the serum, but could not be demonstrated in the 
cerebrospinal fluid. The monkey model therefore permits the study of various aspects of cerebral 
trypanosomiasis. BerenilR treatment is inefficient in patent CNS infection and leads to a protracted, 
less virulent disease course with terminal men~g~ncephalitis and intracerebral “persister” 
trypanosomes. This drug-induced trypanosome shift with me~ngoencepha~tis could be used for 
chemotherapeutic purposes to test new compounds in late stage disease. 
Introduction Laboratory Methods 
Recurrence of trypanosomes in a host treated with 
adequate doses of trypanocides is definitely called a 
relapse, provided that after therapy the host remains 
outside the endemic area or the experimental model 
precludes the possibility of reinfection. 
Some trypanocides can mask an ongoing central 
nervous system (= CNS) involvement by trypano- 
somes. This has been shown in human African 
trypanosomiasis (= HAT) by CALWELL (1937) and 
bv various authors (NEITZ & MCCULLY. 1971: 
JENNINGS et al., 1979;~~~~~~ etal:, 1981, i982) i-d 
experimental African trypanosomtasis (= EAT). 
Since trypanosome-infected vervet monkeys were 
available from a chemotherapeutic project, selected 
biological samples were taken for analysis. This report 
provides some preliminary data in relation to circulat- 
ing immune complexes (= CIC), autoantibodies, 
blob-bran-b~rier, site of trypanosomes in the CNS 
and the topography of histological changes within an 
organ. Berenil (diminazene aceturate) has been 
reported to be curative in trypanosome infected 
vervets (SCHMIDT & SAYER, 1982), but the present 
observations prove that relapses do also occur after 
BerenilR in vervet monkeys. 
The laboratory methods for monitoring the disease have 
been used, as already described (SCHMZDT & SAYER, 1982). 
CIC were determined by the C,, binding assay reported by 
LAMBERT et al. (1981) including a m~~cation for the 
cerebrospinal fluid (= CSF) determination. In the latter, a 
description of the determination of orher constituents uch 
as albumin and immunoglobulins can also be found. 
Drug 
BerenilR was used to prevent death after more than 50 
days of infection when animals were acutely ill. The dosage 
was 5 mgikg per day during three to four days by 
intramuscular injection. Monitorine of such treated vervets 
continued, including repeated lumbar puncture with subse- 
quent centrifugation and mouse inoculation (SCHMIDT & 
SAYER, 1982). 
Histology 
Samples were collected during the post-mortem. Three 
coronal sections of the fresh brain permitted access for 
electron microscopy (= EM) sampling (see below). 
Fixation with formalin, embedding in paraffin and stain- 
ing with haematoxylin and eosin were performed according 
to standard histological techniques. 
Electron Microscopy 
Sampling of brain blocks at the Iareral choroid plexus, 
hypocampus, thalamus and pons was done immediately after 
death in two monkeys. After fixation in 2.5% glutaraldehyde 
the samples were micro-dissected under a stereomicroscope 
in 0*2M cacodvlate buffer. After nost&ation in 2% osmium 
tetroxide the specimens were biockstained in 2% uranyl 
acetate in 70% acetone before further dehydration and 
embedding in Epon according to routine procedures (RUDIN 
et al., 1983). Semi-thin sections were cut for orientation 
using Azur II Methylene blue stain. Subsequently thin 
sections were anatysed using a Philips EM 300. 
Animat 
Materials and Methods 
Four Cercopithecus aethiops (vervet monkey) were pre- 
pared for the experiment as already reported (SCHMIDT & 
SAYER, 1982). 
Typanosomes 
The trypanosome used was a stabilate from T~punosoma 
brucei rho&s&se {= TBR, EATRO 1989) or from T. bracei 
bmcei (= TBB, GUMS 1) as reported by SCHMIDT & SAYER 
(1982) and POLTERA et al. (1980) respectively. The inoculum 
consisted of lo4 trypanosomes per monkey. *address for correspondence 
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Fresh frozen mouse brain was cut s&tally at 4p 
(POLTERA et al., 1980). Test-serum or test-CSF from 
trypanosome-infected vervet monkeys-collected while in 
relapse and shortly before death--was diluted (1: 10,l: 100) 
and exposed to the mouse brain sections. Fluorescent- 
conjugate, coupled with ~~~~ I&i, diluted l:IO, was 
used for staining (Nordic Laboratories). SIides were ex- 
tied under a L&z orthoplan photomicroscope using the 
equipment for ~~ofluorescence. 
ment varied between 37 and 209 days. Histoiogicaily 
all four monkeys showed fully established mening- 
oencephalitis (Fig. 1) with moderate to marked 
perivascular cuffing, micro&l reaction and occasio- 
nal plasma cells free in the neuropil. However, the 
choroid plexuses howed only mild i~~ato~ cell 
infiltration. The trypanosomes were seen diffusely 
scattered throughout he brain, but not in the choroid 
plexuses. This interstitial and extracefiular presence 
was confirmed by electron microscopy in tw6 vervets 
(Fig. 2), from which biological samples were also 
obtained (Monkey No. 33 and No. 52). 
Fig. 3a + b depict the seqential events before and 
after treatment with Berenil in two monkeys (Nos. 
33, 52) in relation to parasites in the blood and CSF 
and to CIC in the serum and CSF. It is evident that 
CIC level off after therapy but increase subsequently 
as relapse is fully established. 
Blood-brain-barrier 
Blood-brain-barrier impairment (Q alb) and intracerebral 
IgG synthesis (Q IgG/Q alb) were calculated with the same 
formulae as referred to by LAMBERT er al. (1981). 
Results 
The relevant data of four trypanosome-infected 
vervet monkeys are presented in Table I. It is 
apparent that the survival time after BerenilR treat- 
Table I-Trypanosoma infected vervet monkeys and treatment failure with RerenilR 
Treatment Post-therapeutic 
Animal Administration Dose Duration Dead survival 
No. Trypanosome (day>* (mg/kg) i.m. (days) f day)* time (days) 
2 TBR B 28, 64 63 : 2x4 is3 37, (2) 
z TBR 64 89 5  4 ; 301 148 209 it 
Key: TBR = EATRO 1989 = T. b. &ode&se 
TBB = GUMS 1 = T. b. bme& 
i-m. = intramuscular 
* = after inoculation 
Fii. 1. Monkey No. 52. Marked encephalitis with p&vascular Fig. 2. Monkey No. 52. Single flagellated (F) trypsnoaome n xt o a 
accumulation f mononuclear cells. V = Vessel umen. H & E, myelin sheath (=M) in the neuropil. Note that interstitial extraceltu- 
x 40. lar iocaiization. EM, X 17000. 
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Fig. 3. Fig. 3a: Monkey No. 33. Fig. 3b: Monkey No. 52. Two 
graphs illustrating the occurrence of parasites and circulating 
Fig. 4. Two fluorescent capillaries (arrows) on the meninges of a 
immune complexes in serum and cerebrospinal fluid related to 
frozen mouse brain serving as antigenic substrate for detection of 
post-inoculation time and Berenila administration. 
circulating antibodies in cerebrospinal fluid (diluted 1: 10) of Monkey 
No. 52. Fluorescein-conjugated anti-human IgG, x 80. 
Table IL-Circulating immune complexes, (CIC) intracerebral immunoglobulin synthesis (IgG) and 
impairment of blood brain barrier (BBB) in trypanosome-infected vecvet monkeys 
CIC 
Infection No. Day Serum CSF 
Intracerebral 
IgG synthesis* 
ImoTaii;r t 
+ 48 34 + - 0.44 None 
+ 
:; 
35 + 00 + 0.1 None 
R$&, 
52 + 0 + 1.5 None 
T:: 
129 + + 17.0 
>300 ii 
Slight 
n + 8.2 None 
Key: 
* = mg/lOO ml CSF No. 48 = infected control 
n = normal value No. T16 = cured control 
Table III-Blood and CSF immunoglobulins in trypanosome-infected vervet monkeys 
kM kG 
Infection No. Day Serum g/l CSF mgil Serum g/l CSF mg/l 
0 Raw 0.85-3.35 15-40 5-50 
+ Range 15-35 +%6 30-50 +296 
Author 
FINK 
et al. 
+ 
Rei&se 
Cured 
48 
:: 
T:: 
34 5.2 5 4 6
129 52 ;:; 
>300 22.8 
28 
141 i 
0 
21.7 26.2 
23.4 35.2 
24.5 
z 
2;: 
113 
P~LTEFu et al. 
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Table II illustrates that the blood-brain-barrier is 
only impaired in one animal but the intracerebral IgG 
synthesis is positive for the two relapse animals. 
Monkey No. 48 served as an infected control without 
encephalitis (but choroid plexitis), since it died from 
marked pancarditis. Monkey T16 was first treated 
with Diamidine Erlangen 102/198 on day 64 for four 
days but relapsed and was then treated with Melar- 
soprol on days 96 to 99. In both situations the dosage 
was 5 mglkg i.m. The monkey remained negative for 
parasites in blood and CSF for more than 200 days 
and it served as a cured control. Although CIC were 
normal in the serum the synthesis for intracerebral 
IgG was positive; there was no impairment of the 
blood-brain-barrier. 
The absence of positive CIC levels in the CSF of all 
animals is to be noted. 
The immunoglobulin (IgM and IgG) results in the 
serum and the CSF of the two relapses (Nos. 33, 52) 
are depicted in Table III using the same controls as in 
Table II. The table further indicates the range for 
normal and trypanosome-infected vervet monk;ys as 
renorted bv FINK et al. (19831. It is evident that the 
values in &onkey No. Si afte; relapse (day 129) are 
frankly positive in the CSF, whereas at day 52- 
before treatment-they were not. All except he cured 
monkey had positive IgM levels in the serum. The 
untreated animal with trypanosomal pancarditis and 
trypanosomal choroid plexitis (No. 48) showed posi- 
tive results for immunoglobulins in the CSF. 
Before killing two animals (Nos. 33,52), the serum 
and CSF samples were tested for autoantibodies with 
a freshly frozen mouse brain serving as antigenic 
substrate. Positive reactions were observed on the 
small blood vessels of the meninges and parenchyma 
with the serum and CSF of the monkev which 
survived (No. 52, Fig. 4) but not with the’choroid 
plexus. In the other case (No. 33) the serum only 
stained small blood vessels of the brain parenchyma 
and the CSF faintly marked the blood vessel of a 
choroid plexus. Neurones were not stained in either of 
these two cases. 
Discussion 
The present results show the usefulness of a 
chemotherapeutic model which is based on CSF 
infiltration by trypanosomes before test drugs are 
administered. Although virulent trypanosomes were 
used, the trypanocide in case of relapse may alter the 
clinical course since the post-therapeutic survival time 
may exceed the average survival time of untreated 
monkeys. Hence a critical and patient long term 
follow-up of treated trypanosome-infected hosts is 
essential before cure is declared. Improvement in 
tissue techniques permitted visualization of trypano- 
somes, particularly with immunofluorescence (POL- 
TERA et al., 1980, 1981, 1982) and electron micros- 
copy (RUDIN et al., 1983), organ transfer experiments 
(JENNINGS et al., 1979) and tissue elution techniques 
(MULUMBA & WBRY, 1983). It appears that trypano- 
somes shift from a choroid plexus and meningeal 
invasion to intracerebral, extracellular-interstitial 
y;*:zation in relapse cases (POLTERA er al., 1981, 
Tfiese “persister” trypanosomes have been found 
interstitiallv bv EM in several chemotheraneutic 
models (RCDIN-et al., 1983) and they appear m&pho- 
logically to be perfectly viable. Apparently trypano- 
somes manage to adapt biochemically to this environ- 
ment. The spontaneous occurrence of interstitial 
intracerebral trypanosomes has also been reported 
(FINK & SCHMIDT, 1979; VAN MARCK er al., 1981; 
POLTERA et al., 1982). Probably the cerebral inter- 
stitium constitutes a site protected from a major 
immune response and most trypanocides. It would be 
of interest to know if neuroleptic phenothiazines also 
prove trypanolytic in z)ioo, and notably in the CNS, as 
opposed to the reported in vitro action (SEEBECK & 
GEHR, 1983). 
Although antigenic variation is considered to be the 
major escape mechanism of the trypanosome from the 
immune response, “hiding” places such as the 
cerebral interstitium and possibly endocardial valves 
(POLTERA et al., 1985) ought to be considered. 
In addition the morphology of the trypanosome 
appears to play a role ‘In esciblishing reiaises after 
chemotheranv (GRAY et al.. 19821. The common 
denominator-of‘ relapses follbwing barious trypano- 
tides (CALWELL, 1937; MCCULLY & NEITZ, 1971; 
POLTERA et al., 1981, 1982; SCHMIDT & SAYER, 
1982; POLTERA, 1983) is the diffuse encephalitis, 
characterized mainly by a vasculitis. This cerebral 
vasculitis is either spontaneously achieved, for exam- 
ple in HAT (POLTERA et al., 1977), or experimentally 
drug induced as already quoted. 
Circulating immune complexes (= CIC) have been 
described in HAT (FRUIT et al., 1977; WHITTLE et 
1980. LAMBERT et uE 
$!&LVA~-&~STRO et al., 1978’: PoL-rEm et al 
1981) and in EAT 
1980) 
After single dose chemotherapy in EAT, CI$‘tend td 
increase (POLTERA et al., 198 1) and their response can 
be immunomodulated (POLTERA et al., 1984). Im- 
mune complexes can mediate vasculitis and in EAT 
deposits of immune complexes have been shown to 
occur in blood vessels including the CNS (POLTERA et 
al., 1980; VAN MARCK et al., 1983). Since CIC were 
demonstrated in CSF of HAT (LAMBERT et al., 
198 l), their participation in blood-brain-barrier al- 
terations maybe considered. Subsequent to the report 
of smooth muscle antibodies in HAT caused bv T. 
gumbiense (see WOLGA et al., 1981) this study &ves 
experimental evidence that such antibodies to blood 
vessels do occur in the blood and CSF of trypano- 
some-infected monkevs. 
Since the partially sbppressed antibody response in 
EAT is restored within hours after single dose theranv 
with BerenilR (ROELANTS et al., 19797 the increase’if 
CIC and antibodies to blood vessels may contribute to 
the vascular leakage-be it oedematous or haemor- 
rhagic-as seen in EAT (POLTERA et al., 1981) or in 
HAT (MANUELIDIS et al., 1956; HALLER et ul., in 
press). The present and published data (LAMBERT et 
ul., 1981) do show a blood-brain-barrier impairment 
in advanced sleeping sickness and this may be 
aggravated by certain trypanocides. Only further, 
more extensive, studies of such available models will 
clarify the interaction of disease stage, immune 
response and new trypanocides with, it is hoped, 
fewer side effects or find ways to control the side 
effects of existing trypanocides. 
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